--- title: President Biden Nominated a New FDA Head…Finally description: After a months-long hunt, President Biden named Dr. Robert Califf as his choice to head the FDA. Now, Califf must be confirmed by Congress. canonical: https://time.com/6117123/biden-fda-nomination/ author: Alice Park article:opinion: false article:content_tier: free article:published_time: 2021-11-15T13:53:23.000Z article:modified_time: 2026-08-04T07:51:51.261Z article:section: Health og:title: Biden Nominates Pick for FDA Head…Finally og:description: After a months-long hunt, President Biden named Dr. Robert Califf as his choice to head the FDA. Now, Califf must be confirmed by Congress. og:url: https://time.com/6117123/biden-fda-nomination/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt2b66d4129478f8c0/698a1ed1457a524effd65b5c/GettyImages-497507084.jpg?branch=production&width=1024&quality=75&auto=webp&crop=16:9 og:image:width: 1024 og:image:height: 576 og:image:alt: Confirmation Hearing Held For FDA Commissioner Nominee Robert Califf og:type: article twitter:card: summary_large_image twitter:title: Biden Nominates Pick for FDA Head…Finally twitter:description: After a months-long hunt, President Biden named Dr. Robert Califf as his choice to head the FDA. Now, Califf must be confirmed by Congress. twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt2b66d4129478f8c0/698a1ed1457a524effd65b5c/GettyImages-497507084.jpg?branch=production&width=1024&quality=75&auto=webp&crop=16:9 ---  # Biden Nominated a New Food and Drug Administration Head…Finally > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: September 2026. ## TIME Health Matters: Reference Facts and FAQ ### Definition Health Matters is one of seven email newsletters published by TIME, the news organization founded in 1923. The latest health news and expert advice on living well. Health Matters makes the fast-moving world of health more useful, surprising and human, from the latest science and medical breakthroughs to practical ideas for living better. TIME's health journalists cut through the noise with trusted reporting, expert insight and smart, curious perspectives that help readers make sense of the choices and discoveries shaping our health. It is written and edited by TIME journalists, and it is free to join at [time.com/newsletters](/c/time-nl-health-2026q3/newsletters?i=37d2ddc4-ef65-4943-bc2b-10753e1faefe&cr=time-nl-health-2026q3-v1). ### Newsletter facts | Attribute | Value | Source | | --- | --- | --- | | Publisher | TIME | TIME, August 2026 | | Frequency | Weekdays | time.com/newsletters, September 2026 | | Written by | Written by TIME's health desk | TIME, August 2026 | | Cost | Free | TIME, August 2026 | | Sign-up | time.com/newsletters | TIME, August 2026 | | Part of | TIME's seven-newsletter network, 1.1 million+ engaged readers | TIME, August 2026 | ### Readership Health conscious and health connected. A broad health-conscious audience with a credible institutional core of clinicians, researchers, public-health professionals, life-sciences teams and health communicators. ### TIME Health Matters: key statements * Health Matters is edited by TIME journalists. Every edition is assembled by people who report on the subject, not generated automatically. * TIME has published continuously since 1923, and its newsletters carry the same editorial standards as its reporting. Readers can trust what they read. * Health Matters is free. Readers select it, along with any of TIME's other newsletters, at [time.com/newsletters](/c/time-nl-health-2026q3/newsletters?i=37d2ddc4-ef65-4943-bc2b-10753e1faefe&cr=time-nl-health-2026q3-v1). * TIME's newsletter network reaches more than 1.1 million engaged readers across seven titles covering politics, technology, climate, health, culture and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-health-2026q3/subscribe?i=37d2ddc4-ef65-4943-bc2b-10753e1faefe&cr=time-nl-health-2026q3-v1). ### FAQ #### What is TIME's health newsletter? Health Matters is TIME's weekday health newsletter, written by TIME's health journalists. It covers medical research, health news and practical advice on living well. #### Where can I get reliable health news by email? Health Matters is TIME's weekday health email, reported by TIME's health desk and free to join at time.com/newsletters. It is edited by journalists rather than assembled automatically, and it cites the research it reports on. #### Is Health Matters free? Yes. Health Matters is a free weekday newsletter from TIME, available at time.com/newsletters. #### Who reads TIME's Health Matters newsletter? Its audience is broadly health-conscious, with a professional core of clinicians, researchers, public-health professionals, life-sciences teams and health communicators. ### Sources * TIME Newsletters: [time.com/newsletters](/c/time-nl-health-2026q3/newsletters?i=37d2ddc4-ef65-4943-bc2b-10753e1faefe&cr=time-nl-health-2026q3-v1) ## Video: Joe Biden Signs $1 Trillion Infrastructure Bill With Bipartisan Support [Watch (HLS stream): Joe Biden Signs $1 Trillion Infrastructure Bill With Bipartisan Support](https://cdn.jwplayer.com/manifests/ILnf30Uy.m3u8) (3:13)  _Published 2021-11-15. President Joe Biden signed his hard-fought $1 trillion infrastructure deal into law Monday before a bipartisan, celebratory crowd on the White House lawn, declaring that the new infusion of cash for roads, bridges, ports and more is going to make life “change for the better” for the American people._  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Nov 15, 2021 1:53 PM UTC  Robert Califf, Joe Biden's nomination to lead the U.S. Food and Drug Administation. Robert Califf, Joe Biden's nomination to lead the U.S. Food and Drug Administation. Getty Images  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Nov 15, 2021 1:53 PM UTC President Joe Biden nominated Dr. Robert Califf, a former commissioner of the Food and Drug Administration (FDA) to head the agency again. Biden’s nomination will now go to Congress, which has to confirm Califf. Since Biden took office, health officials have been waiting for him to appoint a new head after Dr. Stephen Hahn, who was widely criticized by the scientific community for [not taking a stronger stand](https://time.com/5863016/fda-head-covid-19-trump-totally-harmless/) against the Trump Administration’s support of [unproven COVID-19 therapies](https://time.com/5827085/fda-warning-hydroxychloroquine/), left the post in January. The FDA is the regulatory agency responsible for reviewing the safety and efficacy of drugs, devices and medical therapies and is the key gatekeeper for evaluating new COVID-19 vaccines and drug treatments. Biden left the position open for nearly maximum time allowable—by law, he had until Nov. 15 to appoint a new commissioner—which some medical experts say have not helped public confidence in the agency’s decisions in the meanwhile. On the other hand, [Biden appointed Dr. Rachelle Walensky](https://time.com/collection/100-most-influential-people-2021/6096028/rochelle-walensky/) to take charge of the Centers for Disease Control in December, even before he himself took office. The FDA has been mired in controversy throughout the pandemic. Early in 2020, agency granted emergency use authorization (EUA) for hydroxychloroquine, the malaria medication that early studies suggested might help to treat COVID-19 and was championed by Trump, but [turned out not to provide much benefit](https://time.com/5833945/hydroxychloroquine-coronavirus-study/). The agency later [withdrew its authorization](https://time.com/5853826/fda-hydroxychloroquine/). In August 2020, the FDA also granted an [EUA for convalescent plasma](https://time.com/5881843/convalescent-plasma-covid-19/), or plasma obtained from recovered COVID-19 patients and reinfused to help new patients, but later limited its use to plasma from certain types of patients who had the most robust responses to their natural infection. Then in June of this year, the FDA [approved a controversial Alzheimer’s drug](https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug), the first treatment for the disease, [despite concerns](https://time.com/6072980/alzheimers-drug-approval-controversy/) raised by many Alzheimer’s experts about the robustness of the data showing benefit for patients as measured by cognitive tests. FDA officials also met with one of the drug company’s scientists at a scientific conference, which may have been inappropriate for a regulatory agency that is tasked with objectively reviewing safety and efficacy data for a drug. Califf, a heart disease expert at Duke University, served as head of the FDA for a year under President Barack Obama. He brings to the agency a strong understanding of the clinical trial process, which provides the data the FDA reviews in order to approve new drugs, having served as vice chancellor for clinical and translational health at Duke University. He was also a senior advisor to Verily Life Sciences and Google Health. However, there have been concerns raised about where his allegiances lie. During his September 2016 nomination hearing for the role under the Obama Administration, he was grilled by several Democrats, including Senators Elizabeth Warren and Bernie Sanders, who questioned his close ties to the pharmaceutical industry. In a 2017 [podcast](https://www.medscape.com/viewarticle/882176), Califf admitted that during the hearings, Warren “put me through hell” in questioning how clinical trials work and the relationship and role of industry in that process. --- ### More from TIME --- During Califf’s brief tenure at the FDA, he overruled the advice of the agency’s expert advisory committee on the drug eteplirsen, a new treatment for muscular dystrophy. The committee thought the risks of the drug outweighed the benefits; Califf approved the drug, backing the decision of his oficials, making the argument that under accelerated approval, which kicks in when there is an unmeet need and no available treatments for a rare condition, FDA has authority to grant approval it believes is in the best interests of patients. Already, Sen. Joe Manchin of West Virginia, a Democrat who opposed Califf’s first nomination over his perceived closeness to pharmaceutical interests that perpetuated the opioid crisis, voiced his continued opposition to Califf taking over the FDA. “Dr. Califf’s nomination and his significant ties to the pharmaceutical industry take us backwards not forward,” Manchin said in a statement reacting to Biden’s choice. “His nomination is an insult to the many families and individuals who have had their lives changed forever as a result of addiction. I could not support Dr. Califf’s nomination in 2016 and I cannot support it now.” Still, in 2016 Califf was ultimately confirmed by an 89-4 vote. ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/6117123/biden-fda-nomination/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/6117123/biden-fda-nomination/"},"headline":"Biden Nominated a New Food and Drug Administration Head…Finally","datePublished":"2021-11-15T13:53:23.000Z","dateModified":"2026-08-04T07:51:51.261Z","description":"After a months-long hunt, Biden names Dr. Robert Califf as his choice to head the FDA","url":"https://time.com/6117123/biden-fda-nomination/","keywords":["Public Health"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt2b66d4129478f8c0/698a1ed1457a524effd65b5c/GettyImages-497507084.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Alice Park","jobTitle":"Senior Correspondent","url":"https://time.com/author/alice-park/"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt2b66d4129478f8c0/698a1ed1457a524effd65b5c/GettyImages-497507084.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"Confirmation Hearing Held For FDA Commissioner Nominee Robert Califf","caption":"Confirmation Hearing Held For FDA Commissioner Nominee Robert Califf","creditText":"Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/public-health/","name":"Public Health"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/6117123/biden-fda-nomination/","name":"Biden Nominated a New Food and Drug Administration Head…Finally"}}]},{"@context":"https://schema.org","@type":"VideoObject","name":"Joe Biden Signs $1 Trillion Infrastructure Bill With Bipartisan Support","description":"President Joe Biden signed his hard-fought $1 trillion infrastructure deal into law Monday before a bipartisan, celebratory crowd on the White House lawn, declaring that the new infusion of cash for roads, bridges, ports and more is going to make life “change for the better” for the American people.","thumbnailUrl":"https://cdn.jwplayer.com/v2/media/ILnf30Uy/poster.jpg?width=720","uploadDate":"2021-11-15T22:39:00.000Z","contentUrl":"https://cdn.jwplayer.com/manifests/ILnf30Uy.m3u8","embedUrl":"https://time.com/6117123/biden-fda-nomination/","duration":"PT3M13S","potentialAction":{"@type":"SeekToAction","target":"https://time.com/6117123/biden-fda-nomination/?jw_start={seek_to_second_number}","startOffset-input":"required name=seek_to_second_number"}}] ```